Oct 22, 2024 8:10am EDT NeoGenomics Receives New York State Approval for Neo Comprehensive™ Solid Tumor Test
Oct 08, 2024 8:10am EDT NeoGenomics Launches AML Express for Rapid Genetic Profiling of Acute Myeloid Leukemia
Sep 23, 2024 6:47pm EDT NeoGenomics Announces New RaDaR Technology and Resolution of RaDaR 1.0 Litigation
Sep 11, 2024 8:05am EDT NeoGenomics to Present New Data at ESMO 2024, Highlighting the Value of ctDNA and NGS for Advancing Cancer Diagnostics and Personalized Treatment
